Ultragenyx Pharmaceutical (RARE)
(Delayed Data from NSDQ)
$43.85 USD
-0.43 (-0.97%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $43.84 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.72 | 0.00% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$1.52 per share, beating the Zacks Consensus Estimate of $-1.65 per share. This reflects a positive earnings surprise of 7.88%. Look out for RARE's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.72 per share, reflecting a year-over-year increase of 26.18%.
Earnings History
Price & Consensus
Zacks News for RARE
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services